FDA Approves New Dosage Strength for Intelence
Links shared publicly online about this topic.
- 606total visits
FDA Approves New Dosage Strength for Intelence
View full resource at drugs.com
Tags: Infection, HIV, HIV Medication, STD, Drug, FDA, Intelence
Most Recently Shared on January 4, 2011 at 4:10 am By:
FDA Approves New Dosage Strength for Intelence: TITUSVILLE, N.J., Jan. 3, 2011 /PRNewswire/ -- The U.S. Fo... http://bit.ly/fCWTaJ #drug
U.S. FDA Approves New 60 Mg Dosage Strength Of Fluoxetine
medicalnewstoday.com — “Edgemont Pharmaceuticals, LLC, a neuroscience focused company, announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Fluoxetine Tablets 60 mg.” View full resource at medicalnewstoday.com
Most Recently Shared on October 13, 2011 at 9:05 am By:
MNT Drug Approvals Health News
U.S. FDA Approves New 60 Mg Dosage Strength Of Fluoxetine http://t.co/d38EVTiD #regulatory
Fluoxetine 60mg Dosage Strength Tablets Available - MPR
empr.com — “The FDA has approved a 60mg dosage strength tablet of fluoxetine, manufactured by Edgemont Pharmaceuticals.” View full resource at empr.com
Most Recently Shared on October 11, 2011 at 2:32 pm By:
New 60mg Dosage Strength of Fluoxetine Approved http://t.co/XmjF4Vlj #depression #anxiety #OCD
FDA Approves New Dosage Strength For INTELENCE(R)
medicalnewstoday.com — “The U.S. Food and Drug Administration(FDA) approved a label update to include a 200 mg formulation of INTELENCE® (etravirine), a non-nucleoside reverse transcriptase inhibitor (NNRTI) indicate” View full resource at medicalnewstoday.com
Most Recently Shared on January 4, 2011 at 5:05 pm By:
MNT Drug Approvals Health News
FDA Approves New Dosage Strength For INTELENCE(R) http://mnt.to/3PBF #regulatory
Intelence 200mg dosage strength approved - ONA
oncologynurseadvisor.com — “The FDA has approved a 200mg dosage strength of Intelence (etravirine tablets, from Tibotec), a non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated for the treatment of HIV-1 in treatment-experienced adults with resistance to an NNRTI and other antiretroviral agents.” View full resource at oncologynurseadvisor.com
Most Recently Shared on January 3, 2011 at 3:32 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Intelence 200mg dosage strength approved http://goo.gl/fb/xiVQt
Intelence 200mg dosage strength approved - MPR
empr.com — “The FDA has approved a 200mg dosage strength of Intelence (etravirine tablets, from Tibotec), a non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated for the treatment of HIV-1 in treatment-experienced adults with resistance to an NNRTI and other antiretroviral agents.” View full resource at empr.com
Most Recently Shared on January 3, 2011 at 3:27 pm By:
MPR News: Intelence 200mg dosage strength approved: The FDA has approved a 200mg dosage strength of Intelence (e... http://bit.ly/gfbWgo
Abbott's SIMCOR (Niacin Extended-Release / Simvastatin) Receives FDA Approval For New Dosage Strengths - QualityPoint Technologies
qualitypointtech.net — “Abbott has received U.S. Food and Drug Administration (FDA) approval for two new dosage strengths of SIMCOR, a cholesterol medication. The new SIMCOR dosage strengths combine 40 mg of simvastatin - the most commonly prescribed dose of simvastatin - with either 500 mg or 1,000 mg of niacin extended-release. SIMCOR is the first treatment to combine Abbott's proprietary niacin extended-release and simvastatin, the most commonly used statin. SIMCOR is a prescription medication used along with diet i” View full resource at qualitypointtech.net
Most Recently Shared on August 6, 2010 at 2:36 pm By:
Abbott's SIMCOR® (Niacin Extended-Release / Simvastatin) Receives FDA Approval For New Dosage Strengths: Abbott ... http://bit.ly/av13zh
Abbott's Simcor (niacin extended-release/simvastatin) Receives FDA Approval for New Dosage Strengths
drugs.com — “Simcor (niacin ER and simvastatin) is used for Hyperlipidemia. Information from Drugs.com includes Simcor side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on July 30, 2010 at 1:29 am By:
Abbott's Simcor (niacin extended-release/simvastatin) Receives FDA Approval for New Dosage Strengths - http://bit.ly/aBBY2A
Additional dosage strengths of Simcor approved - MPR
empr.com — “Abbott announced that it has received FDA approval for two new dosage strengths of Simcor (niacin extended-release/simvastatin tablets).” View full resource at empr.com
Most Recently Shared on July 29, 2010 at 4:02 pm By:
MPR News: Additional dosage strengths of Simcor approved: Abbott announced that it has received FDA approval for t... http://bit.ly/bSA16u
Additional dosage strengths of Simcor approved - ONA
oncologynurseadvisor.com — “Abbott announced that it has received FDA approval for two new dosage strengths of Simcor (niacin extended-release/simvastatin tablets).” View full resource at oncologynurseadvisor.com
Most Recently Shared on July 29, 2010 at 3:22 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Additional dosage strengths of Simcor approved http://goo.gl/fb/uixm5
For those of us who... | Facebook
fb.me — “National Psoriasis Foundation wrote: For those of us who are on Soriatane... Join Facebook to connect with National Psoriasis Foundation and others you may know.” View full resource at fb.me
Most Recently Shared on February 8, 2010 at 6:02 pm By:
National Psoriasis Foundation Dermatology and Health Organization
For those of us who are on Soriatane Capsules, the FDA approved two new "intermediate strength" dosage levels: 17.5... http://fb.me/5En53x3
Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR® (niacin Extended-release/simvastatin)
medicalnewstoday.com — “Abbott has submitted a supplemental new drug application (snda) to the u.s. food and drug administration (fda) for two new dosage strengths of simcor®, a cholesterol medication. simcor is a fi” View full resource at medicalnewstoday.com
Most Recently Shared on December 12, 2009 at 12:22 pm By:
MedicalNewsToday: Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR® (niacin: http://bit.ly/8fMHnz Full http://bit.ly/78Vmva
Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR(R) (niacin Extended-release/simvastatin)
medicalnewstoday.com — “Abbott (nyse: abt) has submitted a supplemental new drug application (snda) to the u.s. food and drug administration (fda) for two new dosage strengths of simcor®, a cholesterol medication. s” View full resource at medicalnewstoday.com
Most Recently Shared on December 11, 2009 at 3:19 pm By:
MedicalNewsToday: Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR(R) (niacin: http://bit.ly/4HlCmF Full http://bit.ly/7vMN53
Advertisement
